As of Q4'25, Johnson & Johnson's ( JNJ ) Price-to-Sales ( P/S ) ratio stands at 6.162, marking the highest value in the observed period from Q1'23 to Q4'25. This latest data point reflects a notable increase compared to the previous quarter's ratio of 5.045. Over the covered period, the P/S ratio for JNJ has shown moderate volatility with an overall upward trend. After a dip to 3.677 in Q3'23, the ratio steadily climbed, experiencing brief fluctuations but reaching new highs in the last two quarters. This suggests growing investor optimism or valuation expansion relative to sales, particularly in the latter half of 2025.